netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Emerging Vision Scientists Visit Capitol Hill

On September 15, the National Alliance for Eye and Vision Research (NAEVR) held its Advocacy Day, supported by Research to Prevent Blindness (RPB), in which 22 emerging vision scientists conducted 50 Capitol Hill visits to discuss their work and champion the need for continued federal funding for critical vision research.

Emerging vision scientists visit the office of Senator Kirsten Gillibrand

Emerging vision scientists and RPB visit the office of Senator Kirsten Gillibrand 

NAEVR's message that "research does not have a pause button" was well received by congressional staff and the eight members of Congress who met directly with the emerging vision scientists. RPB President Brian Hofland, PhD, accompanied several of the emerging vision scientists on their visits with congressional staff, and stressed the need to fund young researchers through both foundations and non-profits (such as RPB) and federal grants.

The young researchers appreciated the opportunity to speak about their work in a political forum. "Personally, I was quite enlightened by these visits in gaining an understanding of the nuts and bolts of how science policy and funding decisions are made at the government level. I feel that this experience helped me to better develop skills to 'sell research' to non-scientists who play a critical role in funding vision research," said Daniel Chao, MD, PhD, from the University of California San Diego.

Emerging vision scientists at AVER Congressional reception

Emerging vision scientists attend the AVER Congressional reception 

Prior to going to the Hill, on September 14 the emerging vision scientists displayed posters of their research at an evening Congressional reception hosted by the Alliance for Eye and Vision Research (AVER, which is NAEVR's associated non-profit educational organization) at which National Eye Institute Director Paul Sieving, MD, PhD, spoke and members of Congress has a chance to interact with the young researchers.

On September 28, just weeks after Advocacy Day, Congress passed a short-term Continuing Resolution that funds the government through the end of 2016--one of the requests NAEVR, RPB and the emerging vision scientists made at their visits. They also advocated for Congressional representatives to return following the election in November to complete 2017 appropriations, including a $2 billion National Institutes of Health funding increase to $34.1 billion.

 

 

 

Related News: Top Story

eye photo

New Grants for Big Data Research to Improve Vision Care

Read More

 
RPB Logo

Research to Prevent Blindness Opens Applications for Vision Research Grants

The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.

Read More

 
RPB logo

Vision Research Funding Partnership Event Takes Place Today

Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.

Read More

 
Dr. Alex Huang

Research to Prevent Blindness and Alcon Award Glaucoma Grant

Dr. Alex Huang of the University of California San Diego School of Medicine will study glaucoma filtration surgeries with the aim of improving surgical success for lowering eye pressure and providing neuroprotection.

Read More

 
clock icon

Researchers Build An “Aging Clock” To Help Treat Eye Disease

The new way to measure ocular aging opens treatment avenues for numerous eye diseases.

Read More

 
RPB Logo

Research to Prevent Blindness and the American Academy of Ophthalmology Award Big Data Research Grants for Improved Patient Care

The American Academy of Ophthalmology (AAO) and Research to Prevent Blindness (RPB) today announced the 2023 recipients of the RPB/AAO Award for IRIS Registry Research.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.